Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • Analyst Insights & IR
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Alteogen(196170) to Host Corporate Briefing(IR) for Domestic and Foreign Analysts in Yeouido on November 12

Posted on November 8, 2024July 11, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen(196170) to Host Corporate Briefing(IR) for Domestic and Foreign Analysts in Yeouido on November 12

Source Fact: Financial Supervisory Service DART / 2024-11-08

Disclosure Type: Holding of Corporate Briefing (IR)

💡 3-Second Summary

Alteogen will host a face-to-face corporate briefing (IR) for domestic and international securities analysts in Yeouido on November 12 at 4:00 PM KST, featuring a company presentation and an FAQ session.

📊 1. [Summary of Core Disclosure Content and Major Figures]

  • Hosting Entity: Alteogen Co., Ltd. (Ticker: 096170)
  • Date and Time: November 12, 2024 (16:00 ~ 17:00 Local Time)
  • Location: Yeouido area, Seoul
  • Target Audience: Domestic and foreign securities analysts
  • Objective: To enhance analysts’ understanding of the company and ensure the delivery of accurate information.
  • Method: In-person meeting (Face-to-face briefing)
  • Key Agenda: Company introduction and FAQ session
  • IR Materials Availability: Scheduled to be posted on November 12, 2024, via the Korea Exchange Korea Investor’s Network for Disclosure (KIND) website.
  • Confirmation Date: November 08, 2024

📈 2. [Expert View: What This Disclosure Means for Investors]

This disclosure is a routine procedural announcement required by exchange regulations to notify the market of a scheduled investor relations event. The announcement of hosting an IR meeting itself does not cause any immediate alteration to the company’s financial figures, such as assets, liabilities, or revenue, nor does it impact core business contracts. Therefore, it is appropriate to view this as a short-term informational event.

However, since this IR session is structured as an in-person meeting in Yeouido targeting both domestic and international analysts and specifically includes an FAQ segment, it may serve as an avenue to address prevalent market inquiries. The official IR presentation materials are scheduled to be published on the KRX KIND system on the day of the event (November 12). Investors may find it beneficial to monitor the verified data disclosed on that date and assess subsequent research reports issued by institutional analysts to gain clear insights for their portfolio management.

📝 Editor’s Comment (by K-STOCK Editor)

Alteogen is stepping up to directly engage with the market by gathering domestic and international analysts in Yeouido. Reflecting the substantial market interest surrounding the company, they have opted for an ‘in-person meeting’ rather than a virtual or written format, dedicating a segment specifically to FAQs. Typically, these corporate briefings serve as a strategic channel to clear up market ambiguities and improve understanding among institutional and foreign investors. As the official IR materials are slated for release on the KRX KIND website that afternoon, investors would be well-advised to rely on the verified data provided by the management rather than unconfirmed rumors or speculative talk circulating in trading communities.

📢 Disclaimer and Source Information

Source: This content has been structured and newly written based on the official data submitted to the Electronic Disclosure System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Alteogen(196170) Anticipated for ‘Investment Warning’ Designation and Designated as ‘Investment Caution’ Stock Due to Over 200% Surge in a Year
Next Post: [Disclosure] Alteogen(196170) Signs KRW 419.7B Exclusive License Agreement with Daiichi Sankyo for Human Hyaluronidase Technology (ALT-B4)

Related Posts

[Disclosure] Alteogen (196170) to Hold IR Meetings in Hong Kong & Singapore for Global Institutional Investors to Share Mid-to-Long Term Growth Strategy and R&D Progress Disclosures
[Disclosure] Alteogen (196170) to List 146,140 Additional Common Shares Following Stock Option Exercises Disclosures
[Disclosure] Alteogen(196170) Files for Domestic Marketing Authorization of Eylea Biosimilar ‘EYZANFY Inj.’ Disclosures
[Disclosure] Alteogen (196170) to Hold EGM on December 8 for KOSPI Relocation and E-Voting Implementation Disclosures
[Disclosure] Alteogen (196170) to List 40,820 Additional Common Shares Following Executive Stock Option Exercises Disclosures
[Disclosure] Alteogen(196170) Announces Subsidiary Merger: Altos Biologics to Absorb Alteogen Healthcare Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hana Micron (067310) Lifted from Investment Warning Stock Status; Reclassified to Investment Caution on June 9 with Re-designation WarningJuly 8, 2026
  • [Discount Reversal via ADR Listing and Entry into an HBM-Led Super Cycle: SK hynix 000660]July 7, 2026
  • [Discount Narrowing via ADR Listing Momentum and Capital Allocation Diversification: SK Square 402340]July 7, 2026
  • Gaon Cable (000500): Structural Re-rating Driven by North American Infrastructure Expansion and AI Data Center Demand ShocksJuly 7, 2026
  • Hugel (145020): Passing the Trough with Q2 Earnings Surprise and Accelerated U.S. Direct Sales DeploymentJuly 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme